reported that TXNIP antisense cDNA transfection in melanoma cells reduced FasL and CD44 cytokine expression, confirming TXNIP’s role in promoting melanoma cell apoptosis and inhibiting tumor growth (63). The gene discussed is CD44; the disease is neoplasm.